EHR-Enabled Support Teams for High Blood Pressure Management
Trial Summary
What is the purpose of this trial?
The study team will conduct a cluster randomized control trial in 10 NYU primary care practices to assess the effectiveness and implementation of the multicomponent intervention on medication adherence and blood pressure control for patients who are non-adherent to antihypertensive medications.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It focuses on helping patients who are not sticking to their blood pressure medications, so it's likely you will continue your current treatment.
What data supports the effectiveness of the treatment Electronic Health Record (EHR) Enabled Teamlets for high blood pressure management?
Research shows that using electronic health records (EHRs) to link with pharmacy data can help identify patients with high blood pressure who are not taking their medication as prescribed. This approach, combined with team-based care, has been effective in improving medication adherence and managing blood pressure.12345
Is the EHR-Enabled Support Teams approach generally safe for managing high blood pressure?
How is the EHR-Enabled Support Teams treatment for high blood pressure different from other treatments?
The EHR-Enabled Support Teams treatment is unique because it uses electronic health records (EHRs) to automatically identify patients with high blood pressure and low medication adherence, and then combines this data with team-based care to improve medication adherence and blood pressure management.110111213
Research Team
Saul Blecker, MD
Principal Investigator
NYU Langone Health
Eligibility Criteria
This trial is for adults over 18 with high blood pressure, diagnosed as having a reading of at least 140/90 or already on antihypertensive medication. They must have visited an NYULH outpatient clinic between June 2022 and December 2025. Healthcare workers involved include physicians, medical assistants, nurses at NYULH ambulatory locations.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a multicomponent intervention to improve medication adherence and blood pressure control
Follow-up
Participants are monitored for safety and effectiveness after treatment
Treatment Details
Interventions
- Electronic Health Record (EHR) Enabled Teamlets
Find a Clinic Near You
Who Is Running the Clinical Trial?
NYU Langone Health
Lead Sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Collaborator